Mark J. Routbort

11.4k total citations
162 papers, 5.4k citations indexed

About

Mark J. Routbort is a scholar working on Cancer Research, Hematology and Molecular Biology. According to data from OpenAlex, Mark J. Routbort has authored 162 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Cancer Research, 55 papers in Hematology and 46 papers in Molecular Biology. Recurrent topics in Mark J. Routbort's work include Cancer Genomics and Diagnostics (63 papers), Acute Myeloid Leukemia Research (52 papers) and Genomics and Rare Diseases (22 papers). Mark J. Routbort is often cited by papers focused on Cancer Genomics and Diagnostics (63 papers), Acute Myeloid Leukemia Research (52 papers) and Genomics and Rare Diseases (22 papers). Mark J. Routbort collaborates with scholars based in United States, China and Saudi Arabia. Mark J. Routbort's co-authors include Keyur P. Patel, L. Jeffrey Medeiros, Rajyalakshmi Luthra, Rajesh R. Singh, James O McNamara, Rashmi Kanagal‐Shamanna, Hagop M. Kantarjian, Devin K. Binder, Russell R. Broaddus and Bedia A. Barkoh and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Blood.

In The Last Decade

Mark J. Routbort

153 papers receiving 5.3k citations

Peers

Countries citing papers authored by Mark J. Routbort

Since Specialization

Citations

This map shows the geographic impact of Mark J. Routbort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Routbort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Routbort more than expected).

Fields of papers citing papers by Mark J. Routbort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Routbort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Routbort. The network helps show where Mark J. Routbort may publish in the future.

Co-authorship network of co-authors of Mark J. Routbort

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Routbort. A scholar is included among the top collaborators of Mark J. Routbort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Routbort. Mark J. Routbort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time 2025 ·JCO Precision Oncology ·(unknown), Richard K. Yang, Fatima Zahra Jelloul, Rajyalakshmi Luthra, Mark J. Routbort, Hui Chen, Sanam Loghavi, Chi Young Ok, Rashmi Kanagal‐Shamanna, Sinchita Roy‐Chowdhuri, L. Jeffrey Medeiros, Keyur P. Patel	2
2	Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131) 2025 ·Clinical Cancer Research ·Mohamed A. Gouda, Filip Jankú, Ying Yuan, Leylah Drusbosky, Alice P. Chen, (unknown), Keyur P. Patel, Stanley R. Hamilton, Mark J. Routbort, James V. Tricoli, P. Mickey Williams, A. John Iafrate, Jeffrey Sklar, Brent Coffey, Richard F. Little, Carlos L. Arteaga, Peter J. O’Dwyer, Keith T. Flaherty, Lyndsay N. Harris, Funda Meric‐Bernstam	1
3	Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia 2024 ·American Journal of Hematology ·Sanam Loghavi, Qing Wei, Farhad Ravandi, Andres Quesada, Mark J. Routbort, Shimin Hu, Gökçe Törüner, Sa A. Wang, Wei Wang, Roberto N. Miranda, Shaoying Li, Jie Xu, Courtney D. DiNardo, Naval Daver, Tapan M. Kadia, Ghayas C. Issa, Hagop M. Kantarjian, L. Jeffrey Medeiros, Guilin Tang	17
4	Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma 2022 ·JCO Precision Oncology ·Jennifer Wang, (unknown), Xu Li, Maitrayee Goswami, Xiao Zhao, Gilbert J. Cote, Wenyi Wang, Priyanka Iyer, Ramona Dadu, Naifa L. Busaidy, Stephen Y. Lai, Neil D. Gross, Renata Ferrarotto, Charles Lu, G. Brandon Gunn, Michelle D. Williams, Mark J. Routbort, Mark Zafereo, Maria E. Cabanillas	45
5	Germline DNMT3A mutation in familial acute myeloid leukaemia 2020 ·Epigenetics ·Courtney D. DiNardo, Hannah C. Beird, Marcos R. Estecio, Swanand Hardikar, Koichi Takahashi, Sarah A. Bannon, Gautam Borthakur, Elias Jabbour, Curtis Gumbs, Joseph D. Khoury, Mark J. Routbort, Ting Gong, Kimie Kondo, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Taiping Chen, P. Andrew Futreal	7
6	DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease 2019 ·American Journal of Hematology ·Andres Quesada, Mark J. Routbort, Courtney D. DiNardo, Carlos E. Bueso‐Ramos, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, Beenu Thakral, Zhuang Zuo, C. Cameron Yin, Sanam Loghavi, Chi Young Ok, Sa A. Wang, Zhenya Tang, Sarah A. Bannon, Christopher B. Benton, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Rajyalakshmi Luthra, L. Jeffrey Medeiros, Keyur P. Patel	71
7	Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy 2018 ·Molecular Cancer Therapeutics ·Hui Chen, Rajyalakshmi Luthra, Mark J. Routbort, Keyur P. Patel, Maria E. Cabanillas, Russell R. Broaddus, Michelle D. Williams	70
8	P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse‐free survival 2018 ·American Journal of Hematology ·(unknown), (unknown), Sanam Loghavi, Sergej Konoplev, Marina Konopleva, Naval Daver, (unknown), Tapan M. Kadia, Mark J. Routbort, (unknown), Rashmi Kanagal‐Shamanna, Andres Quesada, Elias Jabbour, Steven M. Kornblau, L. Jeffrey Medeiros, Hagop M. Kantarjian, Joseph D. Khoury	16
9	Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories 2018 ·Blood Advances ·Sanam Loghavi, Dawen Sui, Peng Wei, Guillermo Garcia‐Manero, Sherry Pierce, Mark J. Routbort, Elias Jabbour, Naveen Pemmaraju, Rashmi Kanagal‐Shamanna, (unknown), Shimin Hu, Zhuang Zuo, L. Jeffrey Medeiros, Hagop M. Kantarjian, Joseph D. Khoury	29
10	Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor–resistant chronic lymphocytic leukemia with disease progression and Richter transformation 2018 ·Cancer ·Rashmi Kanagal‐Shamanna, Preetesh Jain, Keyur P. Patel, Mark J. Routbort, Carlos E. Bueso‐Ramos, (unknown), Joseph D. Khoury, Rajyalakshmi Luthra, Alessandra Ferrajoli, Michael J. Keating, Nitin Jain, Jan A. Burger, Zeev Estrov, William G. Wierda, Hagop M. Kantarjian, L. Jeffrey Medeiros	77
11	Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes 2017 ·Clinical Cancer Research ·Jonathan M. Loree, Allan Andresson Lima Pereira, Michael Lam, Alexandra N. Willauer, Kanwal Raghav, Arvind Dasari, Van K. Morris, Shailesh Advani, David G. Menter, Cathy Eng, Kenna Shaw, Russell R. Broaddus, Mark J. Routbort, Yusha Liu, Jeffrey S. Morris, Rajyalakshmi Luthra, Funda Meric‐Bernstam, Michael J. Overman, Dipen M. Maru, Scott Kopetz	201
12	Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid 2017 ·Journal of Molecular Diagnostics ·Meenakshi Mehrotra, Rajesh R. Singh, Wei Chen, Richard S.P. Huang, (unknown), Bedia A. Barkoh, (unknown), M. Rosario Hernandez, Carmen Behrens, Keyur P. Patel, Mark J. Routbort, Russell R. Broaddus, L. Jeffrey Medeiros, Ignacio I. Wistuba, Scott Kopetz, Rajyalakshmi Luthra	21
13	Endleukemia Assay v1: Enabling NGS-Based Comprehensive Routine Molecular Profiling of Leukemias in Routine Clinical Care 2017 ·Blood ·Chi Young Ok, (unknown), Rajyalakshmi Luthra, (unknown), (unknown), Sanam Loghavi, Rashmi Kanagal‐Shamanna, Zhuang Zuo, C. Cameron Yin, Mark J. Routbort, Hagop M. Kantarjian, L. Jeffrey Medeiros, Keyur P. Patel	4
14	Persistence of immunophenotypically aberrant CD34+ myeloid progenitors is frequent in bone marrow of patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms treated with hypomethylating agents 2016 ·Journal of Clinical Pathology ·Lanshan Huang, Guillermo Garcia‐Manero, Elias Jabbour, Maitrayee Goswami, Mark J. Routbort, L. Jeffrey Medeiros, Jeffrey L. Jorgensen, Sa A. Wang	7
15	Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC) 2016 ·Clinical Lymphoma Myeloma & Leukemia ·Courtney D. DiNardo, Sarah A. Bannon, Mark J. Routbort, Anna R. Franklin, Maureen E. Mork, Mary Armanios, Emily M. Mace, Jordan S. Orange, (unknown), Jane E. Churpek, Koichi Takahashi, Jeffrey L. Jorgensen, Guillermo Garcia‐Manero, Steve Kornblau, Alison A. Bertuch, Hannah Cheung, Kapil N. Bhalla, P. Andrew Futreal, Lucy A. Godley, Keyur P. Patel	66
16	Hotspot Mutation Panel Testing Reveals Clonal Evolution in a Study of 265 Paired Primary and Metastatic Tumors 2015 ·Clinical Cancer Research ·Rashmi S. Goswami, Keyur P. Patel, Rajesh R. Singh, Funda Meric‐Bernstam, Scott Kopetz, Vivek Subbiah, Ricardo H. Álvarez, Michael A. Davies, Kausar J. Jabbar, Sinchita Roy‐Chowdhuri, Alexander J. Lazar, L. Jeffrey Medeiros, Russell R. Broaddus, Rajyalakshmi Luthra, Mark J. Routbort	59
17	Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients 2015 ·Human Pathology ·Mariko Yabe, L. Jeffrey Medeiros, Guilin Tang, Sa A. Wang, Keyur P. Patel, Mark J. Routbort, Govind Bhagat, Carlos E. Bueso‐Ramos, Jeffrey L. Jorgensen, Rajyalakshmi Luthra, Weina Chen, Tariq Muzzafar, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, Yahya Daneshbod, Masoud Davanlou, Shaoying Li, Ken H. Young, Roberto N. Miranda	11
18	Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response 2014 ·European Journal Of Haematology ·Qi Shen, Juan Ouyang, Guilin Tang, Elias Jabbour, Guillermo Garcia‐Manero, Mark J. Routbort, Sergej Konoplev, Carlos E. Bueso‐Ramos, L. Jeffrey Medeiros, Jeffrey L. Jorgensen, Sa A. Wang	24
19	Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics 2013 ·Modern Pathology ·Rashmi Kanagal‐Shamanna, Bryce P. Portier, Rajesh R. Singh, Mark J. Routbort, Kenneth Aldape, (unknown), (unknown), Neelima G. Reddy, Bedia A. Barkoh, Bal M. Mishra, Abhaya Paladugu, Jawad Manekia, Neda Kalhor, Sinchita Roy‐Chowdhuri, Gregg Staerkel, L. Jeffrey Medeiros, Rajyalakshmi Luthra, Keyur P. Patel	158
20	Selective Inhibition of Kindling Development by Intraventricular Administration of TrkB Receptor Body 1999 ·Journal of Neuroscience ·Devin K. Binder, Mark J. Routbort, Terence E. Ryan, George D. Yancopoulos, James O McNamara	145

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact